Ram Aiyar
CIK: 0001997920
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Korro Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 4, 2026KRRO
Korro Bio, Inc.
Sale(S)Direct5.8K shares at avg. $10.84$63K - May 29, 2026KRRO
Korro Bio, Inc.
Sale(S)Direct15.2K shares at avg. $12.98$197K - May 26, 2026KRRO
Korro Bio, Inc.
Award(A)Direct50K shares at avg. $12.33$617K - Feb 2, 2026KRRO
Korro Bio, Inc.
Award(A)Direct40K shares- - Feb 3, 2025KRRO
Korro Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 4, 2026 | KRRO Korro Bio, Inc. | Sale(S) | 5,802 | $10.84 | $62,917 | Direct |
| May 29, 2026 | KRRO Korro Bio, Inc. | Sale(S) | 15,152 | $12.98 | $196,673 | Direct |
| May 26, 2026 | KRRO Korro Bio, Inc. | Award(A) | 50,000 | $12.33 | $616,500 | Direct |
| Feb 2, 2026 | KRRO Korro Bio, Inc. | Award(A) | 40,000 | - | $0 | Direct |
| Feb 3, 2025 | KRRO Korro Bio, Inc. | Award(A) Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-5 of 5 transactions
About Aiyar Ram
Aiyar Ram (SEC CIK 0001997920) files insider reports with the SEC as President and CEO of Korro Bio, Inc. (KRRO).
Signal8 holds 5 ownership filings by Aiyar Ram, all Form 4s, filed between Feb 5, 2025 and Aug 5, 2026. Those filings report 5 transactions, from Feb 3, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aiyar Ram's filings is in CAMBRIDGE, MA.
Recent filings by Aiyar Ram
- Aug 4, 2026: Open-market sale of KRRO shares (Form 4, code S).
- May 29, 2026: Open-market sale of KRRO shares (Form 4, code S).
- May 26, 2026: Grant or award of KRRO shares (Form 4, code A).
- Feb 2, 2026: Grant or award of KRRO shares (Form 4, code A).
- Feb 3, 2025: Grant or award of KRRO derivative securities (Form 4, code A).
Other insiders filing for Korro Bio, Inc. (KRRO)
- Lynx1 Capital Management LP, 10% Owner
- FORMELA JEAN FRANCOIS, Director
- Dolan Oliver, Senior Vice President, Finance
- Vincent Loic A, Chief Scientific Officer
- Cerio Jeffrey, General Counsel
- Chappell Todd, Chief Operating Officer